Delivery Order SPE2DP20D0002-SPE2DP21F4302
Award Date
6/8/21
Potential Completion Date
6/22/21
Potential Value
$565K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Teva Pharmaceuticals USA, Inc. was awarded an $814,482 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The delivery order, issued on July 22, 2020, requires Teva Pharmaceuticals to deliver the requested pharmaceutical product to a location in Parsippany, New Jersey by July 28, 2020. No subcontractors or set aside designations were identified....
Teva Pharmaceuticals USA, Inc. was awarded a $542,988 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The contract has a period of performance from November 3, 2020 through November 17, 2020, with all work to be completed at Teva's facility in Parsippany, New Jersey. No subcontractors or set aside designations were identified. This delivery...
Teva Pharmaceuticals USA, Inc. was awarded a $564,707.52 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The prime contractor will deliver the requested pharmaceutical products to the place of performance in Parsippany, New Jersey by July 20, 2021, fulfilling the Defense Logistics Agency's requirements under this contract awarded on July 13, 2021. No major subcontractors or set aside designations were indicated. The...
Teva Pharmaceuticals USA, Inc. was awarded a $950,229 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The contract has a period of performance from July 22, 2020 through July 28, 2020, with all work to be completed at Teva's facility in Parsippany, New Jersey. No subcontractors or set aside designations were identified. This delivery order...
Teva Pharmaceuticals USA, Inc. was awarded an $814,482 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The delivery order, issued on December 7, 2020, calls for Teva to supply the viral product to a location in Parsippany, New Jersey, with completion required by December 15, 2020. No subcontractors or set-aside designations were identified. The...
Teva Pharmaceuticals USA, Inc. was awarded a $564,707.52 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The place of performance is Teva's facility located in Parsippany, New Jersey. The delivery order has a period of performance starting on July 13, 2021 through July 20, 2021. No major subcontractors or set aside designations were identified. The DLA supports the Department of Defense by procuring pharmaceuticals and...
Teva Pharmaceuticals USA, Inc. was awarded a $542,988 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply adenovirus type 4. The contract was issued under an indefinite-delivery/indefinite-quantity medical product contract vehicle held by DLA. Teva will deliver the pharmaceutical product to a location in Parsippany, New Jersey between December 7-15, 2020. No subcontractors or set-aside designations were identified. This award supports DLA's...
Teva Pharmaceuticals USA, Inc. was awarded an $847,061 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The contract has a period of performance from May 6, 2021 through May 25, 2021 and will be performed in Parsippany, New Jersey. DLA manages the Department of Defense's worldwide logistics systems and supply chains, procuring medical supplies and pharmaceuticals to support military treatment facilities and troops. This delivery...
The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $564,707.52 firm fixed price delivery order to supply adenovirus type 4. The place of performance is Teva's facility in Parsippany, New Jersey. The contract period runs from April 6, 2021 through April 27, 2021. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical supplies, and equipment. This delivery order allows the agency to obtain...
The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order to supply adenovirus type 4 under contract number 8510134412. The prime contractor Teva Pharmaceuticals will deliver the requested pharmaceutical products from its facility located in Parsippany, New Jersey by September 19, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. This...